Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Related Citations for PubMed (Select 23345506)

1.

Getting rid of MPO-ANCA: a matter of disease subtype.

Bremer JP, Csernok E, Holle J, Gross WL, Moosig F.

Rheumatology (Oxford). 2013 Apr;52(4):752-4. doi: 10.1093/rheumatology/kes412. Epub 2013 Jan 23. No abstract available.

PMID:
23345506
2.

[Anti-neutrophil cytoplasmic antibody(ANCA), MPO-ANCA, PR3-ANCA].

Takizawa H.

Nihon Rinsho. 2010 Jun;68 Suppl 6:694-6. Japanese. No abstract available.

PMID:
20942166
3.

[Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].

Nakano H, Ozaki S.

Rinsho Byori. 2010 May;58(5):480-9. Review. Japanese.

PMID:
20560457
4.

[Immunological tests: Anti-neutrophil cytoplasmic antibody].

Takizawa H.

Nihon Rinsho. 2005 Jul;63 Suppl 7:624-6. Review. Japanese. No abstract available.

PMID:
16111351
5.

Antineutrophil cytoplasmic autoantibodies and clinical phenotype in patients with Churg-Strauss syndrome.

Sinico RA, Bottero P, Guillevin L.

J Allergy Clin Immunol. 2012 Dec;130(6):1440; author reply 1440-1. doi: 10.1016/j.jaci.2012.09.031. Epub 2012 Oct 23. No abstract available.

PMID:
23098809
6.

L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?

Holle JU.

Presse Med. 2013 Apr;42(4 Pt 2):616-9. doi: 10.1016/j.lpm.2013.01.041. Epub 2013 Mar 6. No abstract available.

PMID:
23481358
7.

Current and emerging techniques for ANCA detection in vasculitis.

Csernok E, Moosig F.

Nat Rev Rheumatol. 2014 Aug;10(8):494-501. doi: 10.1038/nrrheum.2014.78. Epub 2014 Jun 3. Review.

PMID:
24890776
8.

Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.

Sinico RA, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C, Grasselli C, Pavone L, Gregorini G, Monti S, Frassi M, Vecchio F, Corace C, Venegoni E, Buzio C.

Arthritis Rheum. 2005 Sep;52(9):2926-35.

9.

International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A.

Am J Clin Pathol. 1999 Apr;111(4):507-13. Review.

PMID:
10191771
10.

[A case of Churg-Strauss syndrome in which positive rheumatoid factor and MPO-ANCA preceded the development of clinical symptoms of vasculitis].

Furuiye M, Konno K, Sumi Y, Ohtani Y, Sawada M, Umino T, Inase N, Miyake S, Yoshizawa Y.

Nihon Kokyuki Gakkai Zasshi. 2001 Jun;39(6):410-4. Japanese.

PMID:
11530389
11.

Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.

Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL.

Ann Intern Med. 1997 Jun 1;126(11):866-73.

PMID:
9163287
12.

L29. Relevance of anti-LAMP-2 in vasculitis: why the controversy.

Kain R.

Presse Med. 2013 Apr;42(4 Pt 2):584-8. doi: 10.1016/j.lpm.2013.01.029. Epub 2013 Feb 28. Review. No abstract available.

PMID:
23453500
13.

Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, L├╝demann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ.

Kidney Int. 1998 Mar;53(3):743-53.

14.

L31. A GWAS in ANCA-associated vasculitis: will genetics help re-define clinical classification?

Lyons PA, Smith KG.

Presse Med. 2013 Apr;42(4 Pt 2):589-91. doi: 10.1016/j.lpm.2013.02.303. Epub 2013 Mar 11. Review. No abstract available.

PMID:
23490642
15.

Biotinylation of ANCA target antigen improves assay performance for PR3-ELISA but not MPO-ELISA.

Hayman MW, Slade CA, Spellerberg MB, O'Donnell JL.

Pathology. 2013 Aug;45(5):525-7. doi: 10.1097/PAT.0b013e3283639bdc. No abstract available.

PMID:
23842044
16.

A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.

Savige JA, Paspaliaris B, Silvestrini R, Davies D, Nikoloutsopoulos T, Sturgess A, Neil J, Pollock W, Dunster K, Hendle M.

J Clin Pathol. 1998 Aug;51(8):568-75.

17.

Anti-myeloperoxidase antibodies in patients with microscopic polyangiitis.

Pradhan VD, Badakere SS, Pawar AR, Almeida AF.

Indian J Med Sci. 2003 Nov;57(11):479-86.

18.

Testing for antineutrophil cytoplasmic antibodies.

Zauli D, Grassi A, Ballardini G, Bianchi FB.

Am J Clin Pathol. 2000 Mar;113(3):455-6. No abstract available.

PMID:
10705826
19.

Influence of myeloperoxidase by anti-myeloperoxidase antibodies and its association with the disease activity in microscopic polyangiitis.

Xu PC, Chen M, Cui Z, Zhao MH.

Rheumatology (Oxford). 2010 Nov;49(11):2068-75. doi: 10.1093/rheumatology/keq203. Epub 2010 Jul 31.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk